HOME › Top Market Reports › Multiplex Assays Market by Product (Consumable (Kits & Reagents, Panels)), Type (Nucleic Acid-Based, Protein-Based), Technology (Pcr, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) - Global Forecast to 2021

Multiplex Assays Market by Product (Consumable (Kits & Reagents, Panels)), Type (Nucleic Acid-Based, Protein-Based), Technology (Pcr, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: August 2016
Report Code: BT 4473

Need for Effective Analytical Platforms in Research to Reduce Operational Costs, Adoption of Companion Diagnostics for Increasing & efficacy of therapies, and Advantages of multiplexing over traditional assays Will Boost the Growth of the Multiplex Assays Market.

The global multiplex assays market is projected to reach USD 3.76 Billion by 2021 from USD 2.66 Billion in 2016, at a CAGR of 7.2% from 2016 to 2021.

The multiplex assays market is segmented on the basis of products & service, type, technology, applications, end user, and region. By products & services, the market is categorized into instruments, consumables, accessories, software, and services. The MRI market by type is divided into nucleic acid-based multiplex assays and protein-based multiplex assays. By technology, the market is divides into multiplex polymerase chain reaction, multiplex arrays, and other technologies.

On the basis of applications, the multiplex assays market is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the multiplex assays market in 2016. Factors such as convenience in performing the assays and faster results offered are driving the growth of this segment.

The end user segment of the multiplex assays market is segmented into academic and research institutes, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end users. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share in 2016.

North America is expected to account for the largest share of the multiplex assays market in 2016. This region is estimated to account for 44.7% of the total market. Europe is the second-largest source, this regional market is driven by the availability of government funds.

Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Particular	Scope
Region	U.S. Europe APAC RoW
Base Year	2015
Forecast Period	2016-2021
Revenue Currency	USD ($)

This research report categorizes the multiplex assays market into the following segments and subsegments:

Multiplex Assays Market, by Products & Services

Instruments
Consumables
- Kits and Reagents
- Panels
Accessories
Software
Services

Multiplex Assays Market, by Type

Nucleic Acid-based Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-based Nucleic Acid Assays
Protein-based Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays

Multiplex Assays Market, by Technology

Multiplex Polymerase Chain Reaction
Multiplex Arrays
- Planar Arrays
- Bead-based Arrays
Other Technologies (SIMOA technology, hydrogel-particle technology, gold nano-particle technology, antibody arrays, and cytometric bead-based arrays)

Multiplex Assays Market, by Application

Research & Development
- Drug Development
- Biomarker Discovery and Validation
Diseases and Disorders
- Infectious Diseases
- Cancer
- Cardiac Diseases
- Autoimmune Diseases
- Alzheimer’s Disease
- Allergies
Companion Diagnostics
Other Applications (Food & Agriculture, Forensic Testing, Bone Metabolism, Fertility, and Toxicology Studies)

Multiplex Assays Market, by End User

Academic and Research Institutes
Hospitals
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Other End Users (Blood Banks, CROs, Forensic Labs, Nursing Homes, and Local Public Health Laboratories)

Multiplex Assays Market, by Region

North America
- U.S.
- Canada
Europe
Asia-Pacific
Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

Further breakdown of the European multiplex assays market to Germany, France, the U.K., Italy, and Spain

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions for the Study
           2.2.4 Report Limitations

3 Executive Summary (Page No. - 30)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 37)
    4.1 Market Overview
    4.2 Geographical Analysis: By Product & Services (2016)
    4.3 Geographical Snapshot
    4.4 Multiplex Assays Market, By End User
    4.5 Multiplex Assays Market, By Type

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Adoption of Companion Diagnostics for Increasing Safety & Efficacy of Therapies
                    5.3.1.2 Need for Effective Analytical Platforms to Reduce Operational Costs
                    5.3.1.3 Advantages of Multiplexing Over Traditional Assays
           5.3.2 Restraints
                    5.3.2.1 High Investment Cost of Multiplex Assay Equipment
                    5.3.2.2 Standardization of Immunoassay Design and Quality Control
           5.3.3 Opportunities
                    5.3.3.1 Increasing Validation of Biomarkers in Molecular and Protein Diagnostics
                    5.3.3.2 Need for High-Throughput and Automated Systems
           5.3.4 Challenges
                    5.3.4.1 Dearth of Skilled Labor
                    5.3.4.2 Development of Assays for All Disease Classes

6 Multiplex Assays Market, By Product and Services (Page No. - 48)
    6.1 Introduction
    6.2 Multiplex Assay Consumables
    6.3 Multiplex Assay Instruments
    6.4 Multiplex Assay Accessories
    6.5 Software and Services

7 Multiplex Assays Market, By Type (Page No. - 55)
    7.1 Introduction
    7.2 Nucleic Acid-Based Multiplex Assays
           7.2.1 Planar Nucleic Acid Assays
           7.2.2 Bead-Based Nucleic Acid Assays
    7.3 Protein-Based Multiplex Assays
           7.3.1 Planar Protein Assays
           7.3.2 Bead-Based Protein Assays

8 Multiplex Assays Market, By Technology (Page No. - 67)
    8.1 Introduction
    8.2 Multiplex Pcr
    8.3 Multiplex Arrays
           8.3.1 Multiplex Planar Arrays
           8.3.2 Multiplex Bead-Based Array
    8.4 Other Technologies

9 Global Multiplex Assays Market, By Application (Page No. - 75)
    9.1 Introduction
    9.2 Research & Development
           9.2.1 Drug Development
           9.2.2 Biomarker Discovery and Validation
    9.3 Diseases & Disorders
           9.3.1 Infectious Diseases
           9.3.2 Cancer
           9.3.3 Cardiac Diseases
           9.3.4 Autoimmune Diseases
           9.3.5 Alzheimer’s Disease
           9.3.6 Allergies
    9.4 Companion Diagnostics
    9.5 Other Applications

10 Multiplex Assays Market, By End User (Page No. - 94)
     10.1 Introduction
     10.2 Pharmaceutical & Biotechnology Companies
     10.3 Academic & Research Institutes
     10.4 Clinical Laboratories
     10.5 Hospitals
     10.6 Other End Users

11 Global Multiplex Assays Market, By Region (Page No. - 104)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia-Pacific
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 128)
     12.1 Overview
     12.2 Competitive Situation and Trends
             12.2.1 New Product Launches
             12.2.2 Agreements, Collaborations, and Partnerships
             12.2.3 Acquisition
             12.2.4 Other Strategies

13 Company Profiles (Page No. - 134)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Introduction
     13.2 Luminex Corporation
     13.3 Thermo Fisher Scientific Inc.
     13.4 Illumina, Inc.
     13.5 Bio-Rad Laboratories Inc.
     13.6 Qiagen N.V.
     13.7 Abcam PLC
     13.8 Becton, Dickinson and Company
     13.9 Merck KGAA
     13.10 Seegene Inc.
     13.11 Meso Scale Diagnostics, LLC.
     13.12 Randox Laboratories Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 159)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports

List of Tables (111 Tables)

Table 1 Global Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 2 Global Multiplex Assay Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 3 Global Multiplex Assay Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 4 North America: Multiplex Assay Consumables Market Size, By Country, 2014–2021 (USD Million)
Table 5 Global Multiplex Assay Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 6 North America: Multiplex Assay Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 7 Global Multiplex Assay Accessories Market Size, By Region, 2014–2021 (USD Million)
Table 8 North America: Multiplex Assay Accessories Market Size, By Country, 2014–2021 (USD Million)
Table 9 Global Multiplex Assay Software and Services Market Size, By Region, 2014–2021 (USD Million)
Table 10 North America: Multiplex Assay Software and Services Market Size, By Country, 2014–2021 (USD Million)
Table 11 Global Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 12 Global Nucleic Acid-Based Multiplex Assays Market, By Type, 2014–2021 (USD Million)
Table 13 Global Nucleic Acid-Based Multiplex Assays Market Size, By Region, 2014–2021 (USD Million)
Table 14 North America: Nucleic Acid-Based Multiplex Assays Market Size, By Country, 2016–2021 (USD Million)
Table 15 Global Planar Nucleic Acid Assays Market, By Region, 2014–2021 (USD Million)
Table 16 North America: Planar Nucleic Acid Assays Market Size, By Country, 2014–2021 (USD Million)
Table 17 Global Bead-Based Nucleic Acid Assays Market Size, By Region, 2014–2021 (USD Million)
Table 18 North America: Bead-Based Nucleic Acid Assays Market Size, By Country, 2014–2021 (USD Million)
Table 19 Global Protein-Based Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 20 Global Protein-Based Multiplex Assays Market Size, By Region, 2014–2021 (USD Million)
Table 21 North America: Protein-Based Multiplex Assays Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Planar Protein Assays Market Size, By Region, 2014–2021 (USD Million)
Table 23 North America: Planar Protein Assays Market Size, By Country, 2014–2021 (USD Million)
Table 24 Global Bead-Based Protein Assays Market Size, By Region, 2014–2021 (USD Million)
Table 25 North America: Bead-Based Protein Assays Market Size, By Country, 2014–2021 (USD Million)
Table 26 Global Multiplex Assays Market Size, By Technology, 2014-2021 (USD Million)
Table 27 Global Multiplex Pcr Market Size, By Region, 2014-2021 (USD Million)
Table 28 North America: Multiplex Pcr Market Size, By Country, 2014–2021 (USD Million)
Table 29 Global Multiplex Arrays Market Size, By Type, 2014-2021 (USD Million)
Table 30 Global Multiplex Arrays Market Size, By Region, 2014-2021 (USD Million)
Table 31 North America: Multiplex Arrays Market Size, By Country, 2014–2021 (USD Million)
Table 32 Global Planar Arrays Market Size, By Region, 2014-2021 (USD Million)
Table 33 North America: Planar Arrays Market Size, By Country, 2014–2021 (USD Million)
Table 34 Global Bead-Based Arrays Market Size, By Region, 2014-2021 (USD Million)
Table 35 North America: Bead-Based Arrays Market Size, By Country, 2016–2021 (USD Million)
Table 36 Global Other Technologies Market Size, By Region, 2014-2021 (USD Million)
Table 37 North America: Other Technologies Market Size, By Country, 2016–2021 (USD Million)
Table 38 Global Multiplex Assays Market Size, By Application, 2014–2021 (USD Million)
Table 39 Global Multiplex Assays Market Size for Research & Development Applications, By Type, 2014–2021 (USD Million)
Table 40 Global Multiplex Assays Market Size for Research & Development Applications, By Region, 2014–2021 (USD Million)
Table 41 North America: Market Size for Research & Development Applications, By Country, 2014–2021 (USD Million)
Table 42 Global Multiplex Assays Drug Development Market Size, By Region, 2014–2021 (USD Million)
Table 43 North America: Multiplex Assays Drug Development Market Size, By Country, 2014–2021 (USD Million)
Table 44 Global Multiplex Assays Biomarker Discovery & Validation Market Size, By Region, 2014–2021 (USD Million)
Table 45 North America: Multiplex Assays Biomarker Discovery & Validation Market Size, By Country, 2014–2021 (USD Million)
Table 46 Global Multiplex Assays Market Size for Disease & Disorder Applications, By Type, 2014–2021 (USD Million)
Table 47 Global Multiplex Assays Market Size for Disease & Disorder Applications, By Region, 2014–2021 (USD Million)
Table 48 North America: Market Size for Disease & Disorder Applications, By Country, 2014–2021 (USD Million)
Table 49 Global Multiplex Assays Market Size for Infectious Diseases Applications, By Region, 2014–2021 (USD Million)
Table 50 North America: Market Size for Infectious Diseases Applications, By Country, 2014–2021 (USD Million)
Table 51 Global Multiplex Assays Market Size for Cancer Applications, By Region, 2014–2021 (USD Million)
Table 52 North America: Market Size for Cancer Applications, By Country, 2014–2021 (USD Million)
Table 53 Global Multiplex Assays Market Size for Cardiac Diseases Applications, By Region, 2014–2021 (USD Million)
Table 54 North America: Market Size for Cardiac Diseases Applications, By Country, 2014–2021 (USD Million)
Table 55 Global Multiplex Assays Market Size for Autoimmune Diseases Applications, By Region, 2014–2021 (USD Million)
Table 56 North America: Market Size for Autoimmune Diseases Applications, By Country, 2014–2021 (USD Million)
Table 57 Global Multiplex Assays Market Size for Alzheimer’s Disease Applications, By Region, 2014–2021 (USD Million)
Table 58 North America: Market Size for Alzheimer’s Disease Applications, By Country, 2014–2021 (USD Million)
Table 59 Global Multiplex Assays Market Size for Allergies Applications, By Region, 2014–2021 (USD Million)
Table 60 North America: Market Size for Allergies Applications, By Country, 2014–2021 (USD Million)
Table 61 Global Multiplex Assays Market Size for Companion Diagnostics, By Region, 2014-2021 (USD Million)
Table 62 North America: Market Size for Companion Diagnostics, By Country, 2014–2021 (USD Million)
Table 63 Global Multiplex Assays Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 64 North America: Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 65 Global Multiplex Assays Market Size, By End User, 2014–2021 (USD Million)
Table 66 Global Multiplex Assays Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 67 North America: Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 68 Global Multiplex Assay Market Size for Academic & Research Institutes, By Region, 2014-2021 (USD Million)
Table 69 North America: Multiplex Assays Market Size for Academic & Research Institutes, By Country, 2014–2021 (USD Million)
Table 70 Global Multiplex Assays Market Size for Clinical Laboratories, By Region, 2014–2021 (USD Million)
Table 71 North America: Multiplex Assays Market Size for Clinical Laboratories, By Country, 2014–2021 (USD Million)
Table 72 Global Multiplex Assays Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 73 North America: Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 74 Global Multiplex Assays Market Size for Others End Users, By Region, 2014-2021 (USD Million)
Table 75 North America: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 76 Multiplex Assays Market Size, By Region, 2014–2021 (USD Million)
Table 77 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 78 North America: Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 79 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 80 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 81 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 82 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 83 U.S.: Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 84 U.S.: Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 85 U.S.: Multiplex Assays Market Size, By Technology, 2014–2021 (USD Million)
Table 86 U.S.: Multiplex Assays Market Size, By Application, 2014–2021 (USD Million)
Table 87 U.S.: Multiplex Assays Market Size, By End User, 2014–2021 (USD Million)
Table 88 Canada: Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 89 Canada: Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 90 Canada: Multiplex Assays Market Size, By Technology, 2014–2021 (USD Million)
Table 91 Canada: Multiplex Assays Market Size, By Application, 2014–2021 (USD Million)
Table 92 Canada: Multiplex Assays Market Size, By End User, 2014–2021 (USD Million)
Table 93 Europe: Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 94 Europe: Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 95 Europe: Multiplex Assays Market Size, By Technology, 2014–2021 (USD Million)
Table 96 Europe: Multiplex Assays Market Size, By Application, 2014–2021 (USD Million)
Table 97 Europe: Multiplex Assays Market Size, By End User, 2014–2021 (USD Million)
Table 98 Asia-Pacific: Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 99 Asia-Pacific: Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 100 Asia-Pacific: Multiplex Assays Market Size, By Technology, 2014–2021 (USD Million)
Table 101 Asia-Pacific: Multiplex Assays Market Size, By Application, 2014–2021 (USD Million)
Table 102 Asia-Pacific: Multiplex Assays Market Size, By End User, 2014–2021 (USD Million)
Table 103 RoW: Multiplex Assays Market Size, By Product and Services, 2014–2021 (USD Million)
Table 104 RoW: Multiplex Assays Market Size, By Type, 2014–2021 (USD Million)
Table 105 RoW: Multiplex Assays Market Size, By Technology, 2014–2021 (USD Million)
Table 106 RoW: Multiplex Assays Market Size, By Application, 2014–2021 (USD Million)
Table 107 RoW: Multiplex Assays Market Size, By End User, 2014–2021 (USD Million)
Table 108 New Product Launches, 2016
Table 109 Agreements, Collaborations, and Partnerships, 2015 & 2016
Table 110 Acquisitions, 2014-2016
Table 111 Other Strategies, 2016

List of Figures (59 Figures)

Figure 1 Research Design
Figure 2 Multiplex Assays Market: Top Down Approach
Figure 3 Multiplex Assays Market: Bottom-Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Multiplex Assays Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 7 Nucleic Acid-Based Multiplex Assays Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 8 Protein-Based Multiplex Assays Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Multiplex Assays Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 10 Multiplex Assays Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 11 Multiplex Assays Market Size, By Product & Services, 2016 vs 2021 (USD Million)
Figure 12 Multiplex Assays Market Size, By End Users, 2016 vs 2021 (USD Million)
Figure 13 Market, By Region, 2016 (USD Million)
Figure 14 Rising Focus on Reducing Operational Costs—Primary Growth Driver of the Market From 2016-2021
Figure 15 Consumables Segment to Account for the Largest Market Share in 2016
Figure 16 APAC Will Be the Fastest-Growing Market From 2016 to 2021
Figure 17 Pharmaceuticals & Biotechnology Companies Segment Will Continue to Dominate the Market in 2021
Figure 18 Nucleic Acid-Based Assays Segment to Account for the Largest Share in 2016
Figure 19 Market Segmentation
Figure 20 Global Multiplex Assays Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Consumables Segment to Dominate the Product and Services Market During the Forecast Period 2016-2021
Figure 22 North America to Dominate Multiplex Assay Consumables Market in the Forecast Period 2016-2021
Figure 23 The Protein Multiplex Assays Segment is Projected to Grow at the Highest CAGR During the Forecast Period 2016-2021
Figure 24 The U.S is Expected to Account for the Largest Share in the North American Nucleic Acid-Based Multiplex Assays Market During the Forecast Period 2016-2021
Figure 25 North America is Expected to Account for the Largest Share of the Planar Nucleic Acid Assays Market During the Forecast Period 2016-2021
Figure 26 The U.S. is Expected to Account for the Largest Share of the Bead-Based Nucleic Acid Assays Market in North America During the Forecast Period 2016-2021
Figure 27 North America is Expected to Account for the Largest Share of the Protein-Based Multiplex Assays Market During the Forecast Period 2016-2021
Figure 28 The U.S is Expected to Account for the Largest Share of the Planar Protein Assays Market in North America During the Forecast Period 2016-2021
Figure 29 Multiplex Arrays Segment to Grow at the Highest CAGR During the Forecast Period (2016-2021)
Figure 30 Planar Arrays Technology Segment to Account for More Than Half of the Multiplex Arrays Market in 2016
Figure 31 North America to Hold the Major Share in the Planar Array Technology Market (2016–2021)
Figure 32 The Research & Development Application Segment is Expected to Account for the Largest Market Share During the Forecast Period, 2016-2021
Figure 33 North America to Dominate the Multiplex Assays Market for Research & Development Applications During the Forecast Period, 2016-2021
Figure 34 North America to Dominate the Multiplex Assays Market for Disease & Disorder Applications During the Forecast Period, 2016-2021
Figure 35 North America to Dominate the Multiplex Assays Market for Companion Diagnostics During the Forecast Period, 2016-2021
Figure 36 Pharmaceutical and Biotechnology Companies to Dominate the Multiplex Assays Market, 2016-2021
Figure 37 North America Forms the Largest Segment in the Multiplex Assays Market for Pharmaceutical & Biotechnology Companies, 2016-2021
Figure 38 U.S. to Dominate the North American Multiplex Assays Market for Clinical Laboratories, 2016-2021
Figure 39 North American Market for Hospitals to Register Highest Growth During the Forecast Period, 2016-2021
Figure 40 Geographic Snapshot (2016): Asia-Pacific Will Be the Fastest-Growing Region By 2021
Figure 41 North America Provides Growth Opportunities for the Market, 2016
Figure 42 North American Market Snapshot
Figure 43 R&D Segment to Dominate the North American Market, By Application, 2016-2021
Figure 44 U.S. Multiplex Bead Arrays Segment is Projected to Grow at the Highest CAGR in the Market, By Technology, 2016-2021
Figure 45 Europe Market Snapshot
Figure 46 Nucleic Acid-Based Assays to Hold the Largest Share in the European Market, By Type, 2016-2021
Figure 47 Pharma & Biotech Segment Expected to Command Largest Share in the APAC End-User Market, 2016-2021
Figure 48 Companies Adopted New Product Launches as Their Key Growth Strategy Between 2014–2016
Figure 49 Battle for Market Share: New Product Launches—The Key Growth Strategy Adopted By Players in the Market From 2014-2016
Figure 50 Geographic Revenue Mix of the Top Five Market Players, 2015
Figure 51 Luminex Corporation: Company Snapshot
Figure 52 Company Snapshot: Thermo Fisher Scientific Inc.
Figure 53 Illumina, Inc.: Company Snapshot
Figure 54 Company Snapshot: Bio-Rad Laboratories Inc.
Figure 55 Company Snapshot: Qiagen N.V.
Figure 56 Abcam PLC: Company Snapshot
Figure 57 Company Snapshot: Becton, Dickinson and Company
Figure 58 Company Snapshot: Merck KGAA
Figure 59 Company Snapshot: Seegene Inc.

The multiplex assays market is projected to reach USD 3.76 Billion by 2021 from USD 2.66 Billion in 2016, growing at a CAGR of 7.2% during the forecast period (2016–2021).

Need for effective analytical platforms in research to reduce operational costs, adoption of companion diagnostics for increasing efficacy of therapies, and advantages of multiplexing over traditional assays are the major drivers of the multiplex assays market. Increasing validation of biomarkers in molecular and protein diagnostic and need for high throughput and more automated systems include data about magnetic beads that allow for more automation are expected to further drive the growth of the multiplex assays market. However, high cost of multiplex assay equipment and standardization of immunoassay design and quality control will restrain the growth of this market.

The multiplex assays market is segmented on the basis of products & service, type, technology, applications, end user, and region. By products & services, the Multiplex Assays market is categorized into instruments, consumables, accessories, software, and services. The market by type is divided into nucleic acid-based multiplex assays and protein-based multiplex assays. By technology, the Multiplex Assays market is divided into multiplex polymerase chain reaction, multiplex arrays, and other technologies.

The multiplex assays market by applications is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the market in 2016. Factors such as convenience and faster results offered by multiplex assays are driving the growth of this segment.

By end user segment, the multiplex assays market is segmented into academic and research institutes, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end users. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share in 2016

The U.S. is expected to account for the largest share of the market in 2016. Europe is accounted for the second-largest share of the market; in this region the availability of government funds has encouraged the research and development of multiplex assays. Asia-Pacific region is estimated to be the fastest growing region in the market during the forecast period as it is an emerging market and it is expected that the adoption of multiplex assays in this region will be high.